Recursion Pharmaceuticals (RXRX) Insider Trading & Ownership $6.00 +0.30 (+5.26%) (As of 11/25/2024 ET) Add Compare Share Share Insider Trades Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrends Recursion Pharmaceuticals (NASDAQ:RXRX) Insider Buying and Selling ActivityCurrentInsider OwnershipPercentage15.75%Number OfInsiders Buying(Last 12 Months)0Number OfInsiders Selling(Last 12 Months)8Amount OfInsider Selling(Last 12 Months)$10.10 M Get RXRX Insider Trade Alerts Want to know when executives and insiders are buying or selling Recursion Pharmaceuticals stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address RXRX Insider Buying and Selling by Quarter Ad Banyan Hill PublishingMUST-SEE: Everyone will be talking about this $2 trillion AI tech boom soonAmazon is making its biggest investment ever… $150 billion to be exact. And one company stands to benefit from this massive capital influx. This company could deliver a huge windfall for investors who get in before this story hits the mainstream, which could happen at any time. Don't miss out... Click here to reveal Amazon’s Secret Partner. Recursion Pharmaceuticals Insider and Congressional Trades History Insiders and Members of Congress Insiders Only Members of Congress Only Transaction Type Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years Time Frame * Start Date * End Date Export to Excel Transaction DateNameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails11/13/2024Michael SecoraCFOSell15,000$7.66$114,900.00 11/12/2024Blake BorgesonDirectorSell11,447$7.64$87,455.08 10/29/2024Blake BorgesonDirectorSell11,447$6.72$76,923.84 10/24/2024Tina MarriottCOOSell6,000$6.31$37,860.00 10/15/2024Blake BorgesonDirectorSell11,447$6.67$76,351.49 10/8/2024Michael SecoraCFOSell15,000$6.32$94,800.00 "This Could Be Worse Than the Great Depression, the Dot-Com Crash, and the 2008 Crisis Combined" (Ad)What Are These Billionaire Investors Afraid Of? Billionaires Warren Buffett, Stanley Druckenmiller, George Soros, and David Tepper have all sold off massive U.S. stock positions, including shares of Nvidia, Apple, and Bank of America. Billionaire Ray Dalio, who runs one of the world’s most successful hedge funds, says, “Things are going to get worse for our economy.” What are these billionaires so worried about?Click here to see why experts and insiders may be preparing for the biggest financial crisis of the 10/2/2024Christopher GibsonCEOSell20,000$6.16$123,200.00 10/1/2024Blake BorgesonDirectorSell11,447$6.22$71,200.34 9/26/2024Tina MarriottCOOSell6,000$7.00$42,000.00 9/17/2024Blake BorgesonDirectorSell11,447$6.84$78,297.48 9/10/2024Michael SecoraCFOSell15,000$6.17$92,550.00 9/4/2024Christopher GibsonCEOSell20,000$6.04$120,800.00 9/3/2024Blake BorgesonDirectorSell11,447$6.27$71,772.69 8/29/2024Tina MarriottCOOSell6,000$7.56$45,360.00 8/20/2024Blake BorgesonDirectorSell11,447$7.12$81,502.64 8/13/2024Michael SecoraCFOSell15,000$6.35$95,250.00 8/7/2024Christopher GibsonCEOSell30,000$7.10$213,000.00 8/6/2024Blake BorgesonDirectorSell11,447$6.82$78,068.54 7/25/2024Tina MarriottCOOSell6,000$8.13$48,780.00 7/23/2024Blake BorgesonDirectorSell11,447$8.48$97,070.56 7/10/2024Christopher GibsonCEOSell50,000$7.48$374,000.00 7/9/2024Blake BorgesonDirectorSell11,447$7.32$83,792.04 7/9/2024Michael SecoraCFOSell15,000$7.32$109,800.00 6/27/2024Tina MarriottCOOSell6,000$7.21$43,260.00 6/25/2024Blake BorgesonDirectorSell11,447$9.51$108,860.97 6/13/2024Michael SecoraCFOSell15,000$9.32$139,800.00 6/11/2024Blake BorgesonDirectorSell11,447$8.45$96,727.15 6/5/2024Christopher GibsonCEOSell50,000$8.42$421,000.00 5/30/2024Tina MarriottCOOSell3,000$8.78$26,340.00 5/28/2024Blake BorgesonDirectorSell11,447$9.17$104,968.99 5/1/2024Christopher GibsonCEOSell50,000$7.73$386,500.00 4/30/2024Blake BorgesonDirectorSell11,447$7.95$91,003.65 4/25/2024Tina MarriottCOOSell3,000$7.67$23,010.00 4/17/2024Michael SecoraCFOSell23,124$7.58$175,279.92 4/16/2024Blake BorgesonDirectorSell11,447$7.66$87,684.02 4/3/2024Christopher GibsonCEOSell40,000$8.84$353,600.00 4/2/2024Blake BorgesonDirectorSell11,447$8.82$100,962.54 3/28/2024Christopher GibsonCEOSell40,000$10.10$404,000.00 3/21/2024Tina MarriottCOOSell8,000$10.75$86,000.00 3/19/2024Blake BorgesonDirectorSell20,054$10.79$216,382.66 140% Yields From Stocks Like Tesla? Here's How (Black Friday Special) (Ad)140% Dividends from stocks like Tesla? Discover How for Just $9! For Black Friday, get the full details of an unique dividend strategy that works with giants like Tesla, Apple, and Amazon - at a 82% discount! Don't miss out on this special offer.Click now to learn how to have the chance at 140% yields before time runs out!3/13/2024Michael SecoraCFOSell25,000$11.03$275,750.00 3/6/2024Christopher GibsonCEOSell36,319$11.86$430,743.34 3/5/2024Blake BorgesonDirectorSell20,054$12.06$241,851.24 2/22/2024Tina MarriottCOOSell8,000$14.89$119,120.00 2/20/2024Blake BorgesonDirectorSell20,054$12.32$247,065.28 2/13/2024Michael SecoraCFOSell25,000$9.86$246,500.00 2/7/2024Christopher GibsonCEOSell48,272$9.22$445,067.84 2/6/2024Blake BorgesonDirectorSell11,447$9.30$106,457.10 1/25/2024Tina Marriott LarsonCOOSell8,000$10.35$82,800.00 1/23/2024Blake BorgesonDirectorSell20,054$10.58$212,171.32 1/16/2024Michael SecoraCFOSell25,000$10.45$261,250.00 1/16/2024Shafique ViraniInsiderSell18,000$10.93$196,740.00 1/9/2024Dean Y LiDirectorSell29,000$13.66$396,140.00 1/3/2024Christopher GibsonCEOSell30,853$9.49$292,794.97 12/26/2023Blake BorgesonDirectorSell20,054$10.63$213,174.02 12/15/2023Shafique ViraniInsiderSell18,000$9.60$172,800.00 12/14/2023Zavain DarDirectorSell20,141$9.00$181,269.00 12/12/2023Blake BorgesonDirectorSell11,447$7.40$84,707.80 12/12/2023Michael SecoraCFOSell25,000$7.39$184,750.00 12/6/2023Christopher GibsonCEOSell59,829$7.49$448,119.21 11/28/2023Blake BorgesonDirectorSell11,447$6.72$76,923.84 (Data available from 1/1/2013 forward) RXRX Insider Trading Activity - Frequently Asked Questions Who is on Recursion Pharmaceuticals's Insider Roster? The list of insiders at Recursion Pharmaceuticals includes Blake Borgeson, Christopher Gibson, Dean Y Li, Michael Secora, Mubadala Investment Co Pjsc, Shafique Virani, Terry-Ann Burrell, Tina Marriott, Tina Marriott Larson, and Zavain Dar. Learn more on insiders at RXRX. What percentage of Recursion Pharmaceuticals stock is owned by insiders? 15.75% of Recursion Pharmaceuticals stock is owned by insiders. Learn more on RXRX's insider holdings. Which Recursion Pharmaceuticals insiders have been buying company stock? The following insider purchased RXRX shares in the last 24 months: Mubadala Investment Co Pjsc ($4,440,853.30). How much insider buying is happening at Recursion Pharmaceuticals? Insiders have purchased a total of 581,017 RXRX shares in the last 24 months for a total of $4,440,853.30 bought. Which Recursion Pharmaceuticals insiders have been selling company stock? The following insiders have sold RXRX shares in the last 24 months: Blake Borgeson ($4,890,579.82), Christopher Gibson ($8,145,291.57), Dean Y Li ($396,140.00), Michael Secora ($3,154,129.92), Shafique Virani ($2,019,258.38), Terry-Ann Burrell ($104,182.25), Tina Marriott ($471,730.00), Tina Marriott Larson ($515,150.00), and Zavain Dar ($181,269.00). How much insider selling is happening at Recursion Pharmaceuticals? Insiders have sold a total of 2,257,011 Recursion Pharmaceuticals shares in the last 24 months for a total of $19,877,730.94 sold. Recursion Pharmaceuticals Key ExecutivesDr. Christopher C. Gibson Ph.D. (Age 41)Co-Founder, CEO & Director Compensation: $806.72kMs. Tina Marriott Larson (Age 49)COO & President Compensation: $702.24kDr. Blake C. Borgeson Ph.D. (Age 42)Co-Founder & Director Compensation: $40kDr. Michael Secora Ph.D. (Age 41)Chief Financial Officer Compensation: $629.78kDr. David J. Mauro M.D. (Age 59)Ph.D., Chief Medical Officer Compensation: $674.74kKevin LeggatVice President of Finance & AccountingMr. Benjamin Mabey M.S. (Age 41)Chief Technology Officer Mr. Jared AllenbachSenior Director of Investor RelationsMr. Nathan HatfieldChief Legal Officer & General CounselMr. Ryan KellyChief Communications Officer More Insider Trading Tools from MarketBeat Related Companies Nuvalent Insider Buying Elanco Animal Health Insider Buying Lantheus Insider Buying Blueprint Medicines Insider Buying Cytokinetics Insider Buying Viking Therapeutics Insider Buying Krystal Biotech Insider Buying TG Therapeutics Insider Buying Avidity Biosciences Insider Buying BridgeBio Pharma Insider Buying Insider Tracking Tools CEO Purchases/Sales CFO Purchases/Sales Top Insider Buying Stocks Top Insider Selling Stocks Insider Trades Screener Insider Trades Newsletter Congressional Stock Trades Insider Trading By Country U.S. Insider Trading Activity Canadian Insider Trading Activity U.K. Insider Trading Activity Australia Insider Trading Activity Latest Articles Insiders Selling Into 3 Rallies: Investors Should Do the OppositeInsiders Bet Big on These Small Cap StocksHere’s Why Etsy Management Is Investing $1 Billion in BuybacksInsider Buying Signals Upside for These 3 StocksBig Buybacks Announced: 3 Stocks Insiders Are Banking On This page (NASDAQ:RXRX) was last updated on 11/26/2024 by MarketBeat.com Staff From Our PartnersTim Sykes’ Urgent Trade Alert: “Make this move now”WARNING: 80 Wall Street banks are gearing up for MASSIVE D.C. shock This $2 trillion D.C. shock is NOT abou...Timothy Sykes | SponsoredMUST-SEE: Everyone will be talking about this $2 trillion AI tech boom soonAmazon is making its biggest investment ever… $150 billion to be exact. And one company stands to benefit...Banyan Hill Publishing | Sponsored140% Yields From Stocks Like Tesla? Here's How (Black Friday Special)140% Dividends from stocks like Tesla? Discover How for Just $9! For Black Friday, get the full details of ...Investors Alley | Sponsored9 hidden AI stocks set to thrive in Trump’s new eraAI ETFs are Booming, But These 9 AI Stocks are Better Plays By 2030, the AI industry is projected to be wor...StockEarnings | SponsoredFormer Trump advisor issues urgent warningElon Musk: “This Is The Most Destructive Force In History” Elon Musk claims a terrifying new economic force...Wide Moat Research | SponsoredCrypto’s next big bull run?Juan Villaverde may be America’s top crypto expert. And he says something big is coming for crypto – on Nov...Weiss Ratings | SponsoredWhat Are Buffett, Dalio, and Druckenmiller So Worried About?"This Will Be Worse Than The Great Depression, The Dot-Com Crash, And The 2008 Crisis Combined" According t...Stansberry Research | SponsoredI was wrong. Dead wrong. Deep inside Silicon Valley the alarm bells are ringing… Jeff Bezos just sold $3 billion in Amazon stock. ...Porter & Company | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Recursion Pharmaceuticals, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Recursion Pharmaceuticals With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free RXRX Stock Alerts